What is he best known for?
The fields of study he is best known for:
Mel Greaves mainly investigates Immunology, Leukemia, Genetics, Haematopoiesis and Fusion gene.
His Immunology research is multidisciplinary, incorporating elements of Clone and Chromosomal translocation.
The concepts of his Leukemia study are interwoven with issues in Molecular genetics, Gene rearrangement, Stem cell and Myeloid.
His study on Genetics is mostly dedicated to connecting different topics, such as Evolutionary biology.
His work is dedicated to discovering how Haematopoiesis, Progenitor cell are connected with Gene expression, Stromal cell and Colony-stimulating factor and other disciplines.
His research in Mutation focuses on subjects like Carcinogenesis, which are connected to Germline mutation, Genome, Human genome, Lymphopoiesis and Kataegis.
His most cited work include:
- Signatures of mutational processes in human cancer (5372 citations)
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus (3081 citations)
- Patterns of somatic mutation in human cancer genomes (2497 citations)
What are the main themes of his work throughout his whole career to date?
Mel Greaves focuses on Immunology, Leukemia, Genetics, Molecular biology and Cancer research.
His work deals with themes such as Progenitor cell, Haematopoiesis and Stem cell, which intersect with Immunology.
His biological study spans a wide range of topics, including Gene rearrangement, Lymphoma, B cell and Chromosomal translocation.
His is involved in several facets of Genetics study, as is seen by his studies on Gene, Fusion gene, Mutation, Allele and Cancer.
Mel Greaves combines subjects such as Cell culture, Myeloid, T cell, Antigen and Monoclonal antibody with his study of Molecular biology.
His Cancer research research is multidisciplinary, incorporating perspectives in ETV6 and Fusion protein.
He most often published in these fields:
- Immunology (34.78%)
- Leukemia (27.83%)
- Genetics (26.38%)
What were the highlights of his more recent work (between 2011-2021)?
- Genetics (26.38%)
- Leukemia (27.83%)
- Immunology (34.78%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Genetics, Leukemia, Immunology, Cancer and Cancer research.
His is doing research in Genome-wide association study, Somatic evolution in cancer, Mutation, Gene and Exome, both of which are found in Genetics.
The study incorporates disciplines such as Gene rearrangement, Immune system and B cell in addition to Leukemia.
He works mostly in the field of Immunology, limiting it down to concerns involving Oncology and, occasionally, Multiple myeloma, Chromosomal translocation, Lenalidomide and Acute lymphocytic leukemia.
He has included themes like Evolutionary biology, Biological evolution and Stem cell in his Cancer study.
His Cancer research research is multidisciplinary, relying on both Cell and Bone marrow, Pathology.
Between 2011 and 2021, his most popular works were:
- Signatures of mutational processes in human cancer (5372 citations)
- Clonal evolution in cancer (1945 citations)
- Genomic Classification and Prognosis in Acute Myeloid Leukemia (1566 citations)
In his most recent research, the most cited papers focused on:
Genetics, Cancer, Leukemia, Immunology and Genome-wide association study are his primary areas of study.
His Genetics study frequently draws connections between adjacent fields such as Evolutionary biology.
The Cancer study combines topics in areas such as Neoplastic cell, Ecology and Evolutionary ecology.
His studies in Leukemia integrate themes in fields like Lineage, Gene, Myeloid, Loss of heterozygosity and Antibody.
His Immunology study integrates concerns from other disciplines, such as Cancer biology, Cancer therapy and Germline.
While the research belongs to areas of Cytidine deaminase, Mel Greaves spends his time largely on the problem of Kataegis, intersecting his research to questions surrounding DNA Mutational Analysis and Exome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
